QILU FDA Approval ANDA 203661

ANDA 203661

QILU

FDA Drug Application

Application #203661

Application Sponsors

ANDA 203661QILU

Marketing Status

Prescription001
Prescription002

Application Products

001INJECTABLE;INJECTIONEQ 1GM BASE/VIAL0CEFAZOLIN SODIUMCEFAZOLIN SODIUM
002INJECTABLE;INJECTIONEQ 2GM BASE/VIAL0CEFAZOLIN SODIUMCEFAZOLIN SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2015-12-28
LABELING; LabelingSUPPL6AP2022-02-24STANDARD

Submissions Property Types

ORIG1Null15
SUPPL6Null15

TE Codes

001PrescriptionAP

CDER Filings

QILU
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 203661
            [companyName] => QILU
            [docInserts] => ["",""]
            [products] => [{"drugName":"CEFAZOLIN SODIUM","activeIngredients":"CEFAZOLIN SODIUM","strength":"EQ 1GM BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/28\/2015","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2015-12-28
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.